Pharmaceuticals, Biotechnology and Life Sciences
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that its Annual Report on Form…
– Compared with placebo, XOFLUZA treatment significantly reduced the likelihood of people developing influenza (flu) after exposure to an infected…
LOS ANGELES–(BUSINESS WIRE)–In the release dated June 2, 2019, please replace the PDF file with the accompanying corrected file. The…
TUSTIN, Calif.–(BUSINESS WIRE)–Aesthetic Management Partners, a business accelerator that delivers growth and innovation strategies in the aesthetic industry, announced today…
DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2019 third quarter earnings results at 7 a.m.…
Approval Based on Results of Phase 3 Trial Evaluating Critically Ill Patients with Pneumonia; 100% of Patients Were on Mechanical…
LabCorp Acquires Envigo’s Global Nonclinical Contract Research Business, Envigo Acquires LabCorp’s Covance Research Products Business BURLINGTON, N.C. & INDIANAPOLIS–(BUSINESS WIRE)–LabCorp®…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational RNA interference (RNAi) therapeutics,…
AstraZeneca and Merck’s LYNPARZA Increased the Median Time Without Disease Progression or Death by 4.2 Months Versus Physician’s Choice of…
Three Independent Directors Nominated to Strengthen Board, Remove Conflicts and Return Control of the Company to Shareholders Commercial Potential of…